Not Yet Recruiting
Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma
NCT07373990
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Cancer, Nasopharyngeal Cancinoma (NPC), +9 more
- Locations
-
Not specified